Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation

Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer

(2016) Dawid Walerych et al.   NATURE CELL BIOLOGY

p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis

(2015) X. Wang et al.   CANCER RESEARCH

Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion

(2015) Diane Ojo et al.   CURRENT MEDICINAL CHEMISTRY

ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation

(2015) Guiyan Xu et al.   JOURNAL OF NEURO-ONCOLOGY

MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer

(2015) T. Ujihira et al.   Scientific Reports

Short Hairpin RNA Library-Based Functional Screening Identified Ribosomal Protein L31 That Modulates Prostate Cancer Cell Growth via p53 Pathway

(2014) Yojiro Maruyama et al.   PLoS One

TSPAN12 is a critical factor for cancer–fibroblast cell contact-mediated cancer invasion

(2014) Ryo Otomo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation

(2013) Konstantin Knoblich et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The ribosomal protein S26 regulates p53 activity in response to DNA damage

(2013) D Cui et al.   ONCOGENE

RNA Sequencing of MCF-7 Breast Cancer Cells Identifies Novel Estrogen-Responsive Genes with Functional Estrogen Receptor-Binding Sites in the Vicinity of Their Transcription Start Sites

(2013) Ryonosuke Yamaga et al.   Hormones & Cancer

Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells

(2012) Yayoi Abe et al.   CANCER SCIENCE

miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver

(2012) Koji Okamoto et al.   EMBO JOURNAL

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Ribosomal protein S14 unties the MDM2–p53 loop upon ribosomal stress

(2012) X Zhou et al.   ONCOGENE

Modulators of Prostate Cancer Cell Proliferation and Viability Identified by Short-Hairpin RNA Library Screening

(2012) Kimberly Brown Dahlman et al.   PLoS One

Proteasome inhibitors in cancer therapy

(2011) Lisa J. Crawford et al.   Journal of Cell Communication and Signaling

Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth

(2010) K Ueyama et al.   CANCER GENE THERAPY

Functional screening using a microRNA virus library and microarrays: a new high-throughput assay to identify tumor-suppressive microRNAs

(2010) Masashi Izumiya et al.   CARCINOGENESIS

Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells

(2010) K Takayama et al.   ONCOGENE

Silencing of Ribosomal Protein S9 Elicits a Multitude of Cellular Responses Inhibiting the Growth of Cancer Cells Subsequent to p53 Activation

(2010) Mikael S. Lindström et al.   PLoS One

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

(2009) Balazs Györffy et al.   BREAST CANCER RESEARCH AND TREATMENT

Combination of Proteasome and HDAC Inhibitors for Uterine Cervical Cancer Treatment

(2009) Z. Lin et al.   CLINICAL CANCER RESEARCH

The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability

(2009) R Seth et al.   JOURNAL OF CLINICAL PATHOLOGY

Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)

(2009) A Arlt et al.   ONCOGENE

The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells

(2009) S. B. Coffelt et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance

(2008) Grazia Arpino et al.   ENDOCRINE REVIEWS